Barinthus Biotherapeutics (BRNS) EBT Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.34% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -51.60% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -313.33% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -79.57% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 71.54% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 71.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.80% |
| Dec 31, 2025 | 45.79% |
| Sep 30, 2025 | -80.05% |
| Jun 30, 2025 | -24.78% |
| Mar 31, 2025 | -26.50% |
| Dec 31, 2024 | -13.68% |
| Sep 30, 2024 | 44.73% |
| Jun 30, 2024 | 32.09% |
| Mar 31, 2024 | 16.98% |
| Dec 31, 2023 | 21.88% |
| Sep 30, 2023 | -294.95% |
| Jun 30, 2023 | -268.95% |
| Mar 31, 2023 | -1,195.21% |
| Dec 31, 2022 | -38.93% |
| Sep 30, 2022 | 236.33% |
| Jun 30, 2022 | 187.71% |
| Mar 31, 2022 | 119.40% |
| Dec 31, 2021 | -36.06% |
| Sep 30, 2021 | -130.96% |
| Jun 30, 2021 | -288.49% |